Home > News > Health > FTC decision does not impact Carson Tahoe Cardiology

FTC decision does not impact Carson Tahoe Cardiology

By ThisIsReno


CARSON CITY — Carson Tahoe Cardiology (CTC), a wholly-owned subsidiary of Carson Tahoe Health, was formed in November, 2010.  While not part of the recent Federal Trade Commission investigation, CTC has received several inquiries from patients regarding yesterday’s ruling by the Federal Trade Commission.

“Carson Tahoe Cardiology and our 10 cardiologists are not impacted by the recent Federal Trade Commission ruling against Renown Health.  We want the community to know that Carson Tahoe Cardiology remains intact. We are committed to the Carson Tahoe community and look forward to serving this region for many years to come,” said Dr. David Baker, President of Carson Tahoe Cardiology.

About CTC
With a new state-of-the-art regional medical center as its hub, Carson Tahoe Cardiology treats all stages of cardiovascular disease in Northern Nevada and the surrounding areas. CTC’s patient care model keeps costs low by performing diagnostic testing in outpatient hospital departments whenever appropriate. With office locations in Carson City, Reno, Yerington, South Lake Tahoe and Mammoth Lakes, California, CTC serves a population of more than 250,000.

Never miss a story

Get independent Reno news headlines in your inbox five days a week.

Email field is required to subscribe.